{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:40Z","timestamp":1787020300446,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University Medical Center Mannheim, University Heidelberg","award":["90703061"],"award-info":[{"award-number":["90703061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis is a chronic inflammatory skin disease associated with a reduced life-quality. Severe disease forms put the patients at risk for life-treating cardiovascular events, metabolic, and other immune-mediated disorders. Psoriasis patients are often not sufficiently informed about their condition leading to suboptimal treatment adherence and, consequently, worse patient outcome. We investigated the value of an educational program on knowledge and self-expertise about the disease in psoriasis patients in general and dependent on age and disease duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Regular visit psoriasis-patients were asked to participate and choose to receive an additional educational program or not. Participating patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200953) filled out two questionnaires: one at study inclusion and one at the next regular visit or after the absolved educational program. Surveys included disease knowledge assessment and numeric rating scales (0\u201310) for self-expertise about the disease, therapy adherence, and therapy satisfaction. The Dermatology Life Quality Index (DLQI) was used to investigate the quality of life.\n                    <\/jats:p>\n                    <jats:p>All continuous parameters were examined for statistically significant differences by paired t-test or unpaired t-test. Continuous parameters without Gaussian distribution were analyzed with the Wilcoxon matched pairs test or the Mann-Whitney test. For all categorical parameters, Fisher\u2019s exact test was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients who chose to be educated (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924) showed a significant increase in knowledge, self-expertise about the disease and amelioration of general health. No positive short-term effects were seen on the quality of life and therapy adherence. Analyzing the effect of age and disease duration, the educational program led to significant improvement of the emotional well-being in older patients (\u226550\u2009years) and with a longer disease duration as well as significant amelioration of the self-expertise about psoriasis in younger patients (&lt;\u200950\u2009years).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients who chose to participate in an educational program show a higher gain in knowledge and self-expertise about the psoriatic disease. Educational program thus might have a positive effect on the long-term management of psoriasis. Further long-term studies are needed to provide evidence for the influence educational programs have on outcome, quality of life, and treatment adherence of psoriatic patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Deutsches Register Klinischer Studien\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00017318\">DRKS00017318<\/jats:ext-link>\n                      (09.10.2019), retrospectively registered.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-019-7778-x","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T01:03:03Z","timestamp":1574125383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Analyzing the value of an educational program for psoriasis patients: a prospective controlled pilot study"],"prefix":"10.1186","volume":"19","author":[{"given":"Corinna","family":"Bubak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthe-Lisa","family":"Schaarschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sch\u00f6ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke Katharina","family":"Peitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6421-9699","authenticated-orcid":false,"given":"Astrid","family":"Schmieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"issue":"1","key":"7778_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","volume":"38","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38(1):11\u201327.","journal-title":"Semin Immunopathol"},{"issue":"9997","key":"7778_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP. Psoriasis. Lancet (London Engl). 2015;386(9997):983\u201394.","journal-title":"Lancet (London Engl)"},{"issue":"6","key":"7778_CR3","first-page":"806","volume":"16","author":"A Nast","year":"2018","unstructured":"Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, et al. S3 guideline for the treatment of psoriasis vulgaris, update - short version part 2 - special patient populations and treatment situations. Journal der Deutschen Dermatologischen Gesellschaft. J German Soc Dermatol. 2018;16(6):806\u201313.","journal-title":"J German Soc Dermatol"},{"key":"7778_CR4","doi-asserted-by":"publisher","unstructured":"Korman NJ. Management of psoriasis as a systemic disease: What is the evidence? Br J Dermatol. 2019. https:\/\/doi.org\/10.1111\/bjd.18245.","DOI":"10.1111\/bjd.18245"},{"issue":"2","key":"7778_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1468-3083.2012.04451.x","volume":"27","author":"D Bohm","year":"2013","unstructured":"Bohm D, Stock Gissendanner S, Bangemann K, Snitjer I, Werfel T, Weyergraf A, et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol. 2013;27(2):220\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"7778_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1468-3083.2011.04000.x","volume":"26","author":"TM Ljosaa","year":"2012","unstructured":"Ljosaa TM, Mork C, Stubhaug A, Moum T, Wahl AK. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol. 2012;26(1):29\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3 Pt 1","key":"7778_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","volume":"41","author":"SR Rapp","year":"1999","unstructured":"Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"7778_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000329026","volume":"222","author":"M Augustin","year":"2011","unstructured":"Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA. Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011;222(4):363\u201374.","journal-title":"Dermatology"},{"issue":"1","key":"7778_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/bjd.12039","volume":"168","author":"RJ Thorneloe","year":"2013","unstructured":"Thorneloe RJ, Bundy C, Griffiths CE, Ashcroft DM, Cordingley L. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168(1):20\u201331.","journal-title":"Br J Dermatol"},{"issue":"6","key":"7778_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2340\/00015555-0145","volume":"86","author":"C Renzi","year":"2006","unstructured":"Renzi C, Di Pietro C, Gisondi P, Chinni LM, Fazio M, Ianni A, et al. Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. Acta Derm Venereol. 2006;86(6):528\u201334.","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"7778_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1365-2230.2011.04126.x","volume":"36","author":"C Renzi","year":"2011","unstructured":"Renzi C, Di Pietro C, Tabolli S. Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. Clin Exp Dermatol. 2011;36(8):885\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"7778_CR12","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/nutd.2012.26","volume":"2","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2012;2:e54.","journal-title":"Nutr Diabetes"},{"issue":"5","key":"7778_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1203475415586332","volume":"19","author":"P Fleming","year":"2015","unstructured":"Fleming P, Kraft J, Gulliver WP, Lynde C. The relationship of obesity with the severity of psoriasis: a systematic review. J Cutan Med Surg. 2015;19(5):450\u20136.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"7778_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2340\/00015555-1022","volume":"91","author":"J de Bes","year":"2011","unstructured":"de Bes J, Legierse CM, Prinsen CA, de Korte J. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol. 2011;91(1):12\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"7778_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.rehab.2010.09.003","volume":"53","author":"V Gremeaux","year":"2010","unstructured":"Gremeaux V, Coudeyre E. The internet and the therapeutic education of patients: a systematic review of the literature. Annals Phys Rehabil Med. 2010;53(10):669\u201392.","journal-title":"Annals Phys Rehabil Med"},{"issue":"5","key":"7778_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1365-2133.2012.11113.x","volume":"167","author":"J Bostoen","year":"2012","unstructured":"Bostoen J, Bracke S, De Keyser S, Lambert J. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. Br J Dermatol. 2012;167(5):1025\u201331.","journal-title":"Br J Dermatol"},{"issue":"9","key":"7778_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/1346-8138.12583","volume":"41","author":"Y Chen","year":"2014","unstructured":"Chen Y, Xin T, Cheng AS. Evaluating the effectiveness of psychological and\/or educational interventions in psoriasis: a narrative review. J Dermatol. 2014;41(9):775\u20138.","journal-title":"J Dermatol"},{"issue":"6","key":"7778_CR18","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1111\/bjd.13363","volume":"171","author":"MH Larsen","year":"2014","unstructured":"Larsen MH, Krogstad AL, Aas E, Moum T, Wahl AK. A telephone-based motivational interviewing intervention has positive effects on psoriasis severity and self-management: a randomized controlled trial. Br J Dermatol. 2014;171(6):1458\u201369.","journal-title":"Br J Dermatol"},{"issue":"6","key":"7778_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"1","key":"7778_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/idoj.IDOJ_111_17","volume":"9","author":"P Nagarajan","year":"2018","unstructured":"Nagarajan P, Thappa DM. Effect of an educational and psychological intervention on knowledge and quality of life among patients with psoriasis. Indian Dermatol Online J. 2018;9(1):27\u201332.","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"7778_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000250826","volume":"219","author":"V Lora","year":"2009","unstructured":"Lora V, Gisondi P, Calza A, Zanoni M, Girolomoni G. Efficacy of a single educative intervention in patients with chronic plaque psoriasis. Dermatology. 2009;219(4):316\u201321.","journal-title":"Dermatology"},{"issue":"1","key":"7778_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2004.10.011","volume":"38","author":"N Kanda","year":"2005","unstructured":"Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38(1):1\u20137.","journal-title":"J Dermatol Sci"},{"issue":"5","key":"7778_CR23","first-page":"257","volume":"61","author":"CM Mowad","year":"1998","unstructured":"Mowad CM, Margolis DJ, Halpern AC, Suri B, Synnestvedt M, Guzzo CA. Hormonal influences on women with psoriasis. Cutis. 1998;61(5):257\u201360.","journal-title":"Cutis"},{"key":"7778_CR24","doi-asserted-by":"publisher","first-page":"571912","DOI":"10.1155\/2013\/571912","volume":"2013","author":"R Ceovic","year":"2013","unstructured":"Ceovic R, Mance M, Bukvic Mokos Z, Svetec M, Kostovic K, Stulhofer BD. Psoriasis: female skin changes in various hormonal stages throughout life--puberty, pregnancy, and menopause. Biomed Res Int. 2013;2013:571912.","journal-title":"Biomed Res Int"},{"issue":"5","key":"7778_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5114\/pdia.2014.44010","volume":"31","author":"A Reich","year":"2014","unstructured":"Reich A, Welz-Kubiak K, Rams L. Apprehension of the disease by patients suffering from psoriasis. Postepy Dermatol Alergol. 2014;31(5):289\u201393.","journal-title":"Postepy Dermatol Alergol"},{"issue":"4","key":"7778_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/1346-8138.12804","volume":"42","author":"H Saeki","year":"2015","unstructured":"Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A, et al. Poor adherence to medication as assessed by the Morisky medication adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015;42(4):367\u201372.","journal-title":"J Dermatol"},{"issue":"11","key":"7778_CR27","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12325-015-0256-7","volume":"32","author":"E Vangeli","year":"2015","unstructured":"Vangeli E, Bakhshi S, Baker A, Fisher A, Bucknor D, Mrowietz U, et al. A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Adv Ther. 2015;32(11):983\u20131028.","journal-title":"Adv Ther"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7778-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-7778-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7778-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T21:24:42Z","timestamp":1665005082000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-7778-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7778"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-7778-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"15 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committees of the Medical Faculty Mannheim, Heidelberg University (Ethics Approval 2016-597\u2009N-MA) and performed according to the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients willing to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. Peitsch served as investigator for AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen-Cilag, Merck, Novartis, Pfizer and UCB Pharma; participated in a clinical trial supported by Array Biopharma and MSD; was member of advisory boards of Eli Lilly, LEO Pharma, MSD, Novartis, Pfizer and UCB Pharma; obtained honoraria from ALK-Abello, AbbVie, Biotest, BMS, Janssen-Cilag, MSD, Novartis, Pfizer, Dr. Pfleger GmbH and Roche; and received support for conferences from AbbVie, Actelion, ALK-Abello, Alma Lasers, Almirall, ARC Lasers, Asclepion, BMS, Celgene, Dermapharm, Dermasence, Galderma, GSK, Janssen-Cilag, L\u2019Oreal, La Roche Posay, LEO Pharma, Medac, MSD, Novartis, Pierre Fabre, P&M Cosmetics, Pfizer and Roche. Dr. Schaarschmidt conducted clinical trials for Novartis, Janssen-Cilag, Merck, LEO Pharma, Abbvie, and Celgene and received financial support for participation in conferences from Abbvie, ALK-Abello, Biogen Inc. and MSD. Dr. Schmieder conducted clinical trials for Novartis, Janssen-Cilag, Merck, LEO Pharma, Boehringer-Ingelheim, Abbvie, Eli Lilly, Celgene and Pfizer, received honoraria from Novartis and Janssen-Cilag and obtained support for conferences from Abbvie, Novartis, Janssen-Cilag and Pfizer. Mrs. Corinna Bubak and Mrs. Lisa Sch\u00f6ben have no conflict of interest to declare. The study presented here was not supported by pharmaceutical companies, and the conflicts of interest have no impact on its content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1535"}}